Close Menu

NEW YORK (GenomeWeb) – San Diego-based Diagnomics will begin offering comprehensive and customized pharmacogenetic test reports through a strategic partnership with Translational Software.  

The PGx analysis will be performed on Illumina's Global Screening Array and a comprehensive report on how the detected markers are likely to impact the patient's drug response, metabolism, and treatment efficacy will be generated using Translational Software's platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.